Trials / Conditions / Recurrent Renal Pelvis Urothelial Carcinoma
Recurrent Renal Pelvis Urothelial Carcinoma
5 registered clinical trials studyying Recurrent Renal Pelvis Urothelial Carcinoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Testing Combination Erdafitinib and Enfortumab Vedotin in Metastatic Bladder Cancer After Treatment With Chemo NCT04963153 | National Cancer Institute (NCI) | Phase 1 |
| Active Not Recruiting | ARID1A and/or KDM6A Mutation and CXCL13 Expression NCT04953104 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | Atezolizumab and CYT107 in Treating Participants With Locally Advanced, Inoperable, or Metastatic Urothelial C NCT03513952 | National Cancer Institute (NCI) | Phase 2 |
| Active Not Recruiting | Atezolizumab With or Without Eribulin Mesylate in Treating Patients With Recurrent Locally Advanced or Metasta NCT03237780 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Erlotinib Hydrochloride in Treating Participants With Muscle Invasive or Recurrent Urothelial Cancer NCT00749892 | M.D. Anderson Cancer Center | Phase 2 |